ONCSM vs TCELL Comparison
Price, market cap, valuation, profitability and leverage metrics of ONCSM and TCELL side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | ONCSM | TCELL | Sector median |
|---|---|---|---|
| Last price (TL) | 84.20 | 98.40 | 18.72 |
| Daily change | −5.50% | −1.55% | −4.59% |
| Market cap | TRY 2B | TRY 216.5B | TRY 4.4B |
| P/E | 26.70 | 10.44 | 18.20 |
| P/B | 4.21 | 0.71 | 1.14 |
| Dividend yield | — | 1.87% | 0.90% |
| Return on equity | 18.26% | 7.62% | 1.78% |
| Free float | 40.86% | 38.73% | 37.21% |
Popular comparisons
Related pages
About the ONCSM vs TCELL comparison
Price, market cap, valuation multiples, profitability and leverage of ONCSM (Oncosem Onkolojik Sistemler) and TCELL (Turkcell) side by side as of Sep 28, 2026, 11:56. Of the 16 metrics compared, ONCSM leads in 9 and TCELL leads in 7.
Highlights: Daily change: TCELL leads (−1.55% vs −5.50%). Market cap: TCELL leads (TRY 216.5B vs TRY 2B). P/E: TCELL leads (10.44 vs 26.70). P/B: TCELL leads (0.71 vs 4.21). EV/EBITDA: TCELL leads (3.14 vs 7.50). EV/Sales: TCELL leads (2.30 vs 4.76). Gross margin: ONCSM leads (54.30% vs 25.26%). EBITDA margin (annual): TCELL leads (46.01% vs 41.91%).
Frequently asked questions
Is ONCSM or TCELL cheaper?
By P/E, TCELL is cheaper (26.70 vs 10.44); by P/B, TCELL trades at the lower multiple (4.21 vs 0.71).
Which is more profitable, ONCSM or TCELL?
Annual net margin is 10.83% for ONCSM and 8.91% for TCELL; return on equity is 18.26% for ONCSM and 7.62% for TCELL.
Which is more leveraged, ONCSM or TCELL?
The leverage ratio is 44.59 for ONCSM and 53.09 for TCELL; net debt/EBITDA is 0.48 for ONCSM and 0.89 for TCELL. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.